Clinical Trial Update: A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis [Phase 2]

View source ↗

Summary

Phase 2 trial tested different doses of BI-1291583 in bronchiectasis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• BI-1291583

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Bronchiectasis | Phase 2 | Status: COMPLETED